INFORMATION ABOUT COMPONENTS OF CONSOLIDATED STATEMENTS OF FINANCIAL POSITION - Private Warrants (Details)
|
|
|
12 Months Ended |
|
Mar. 14, 2019
USD ($)
$ / shares
|
Mar. 02, 2018
shares
|
Jun. 30, 2020
USD ($)
$ / shares
|
Jun. 30, 2019
USD ($)
$ / shares
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Private Warrants, Non-Current |
|
|
$ 1,686,643
|
$ 2,861,511
|
| Private warrants |
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Warrant exercise period |
5 years
|
|
|
|
| Warrants incorporate in the reverse capitalization as reduction of equity |
$ 1,589,548
|
|
|
|
| Number of instruments or interests issued or issuable |
12,700,000
|
|
|
|
| Financial liabilities, at fair value |
$ 3,400,000
|
|
1,700,000
|
2,800,000
|
| Gain recognized from change in fair value |
|
|
$ 1,200,000
|
$ 600,000
|
| Private warrants | Volatility |
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Assumption used in estimating fair value | $ / shares |
32
|
|
|
|
| Private warrants | Share price |
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Assumption used in estimating fair value | $ / shares |
5.35
|
|
6.06
|
5.30
|
| Private warrants | Risk-free rate |
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Assumption used in estimating fair value |
2.43
|
|
0.29
|
1.7631
|
| Private warrants, strike price $15.00 |
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Warrants strike price |
15.00
|
|
|
|
| Number of instruments or interests issued or issuable |
2,500,000
|
|
|
|
| Private warrants, strike price $18.00 |
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Warrants strike price |
18.00
|
|
|
|
| Number of instruments or interests issued or issuable |
2,500,000
|
|
|
|
| Founder warrants |
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Warrants incorporate in the reverse capitalization as reduction of equity |
$ 1,843,175
|
|
|
|
| Number of instruments or interests issued or issuable |
5,200,000
|
|
|
|
| Bioceres warrants |
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Number of instruments or interests issued or issuable |
7,500,000
|
|
|
|
| UAC |
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Number of warrants issued in IPO | shares |
|
5,200,000
|
|
|
| Warrants strike price |
|
11.50
|
|
|
| Warrant exercise period |
|
5 years
|
|
|
| UAC | Private warrants, strike price $11.50 |
|
|
|
|
| INFORMATION ABOUT COMPONENTS OF EQUITY |
|
|
|
|
| Warrants strike price |
11.50
|
|
|
|
| Number of instruments or interests issued or issuable |
2,500,000
|
|
|
|
| Share price at which warrants become exercisable | $ / shares |
$ 15.00
|
|
|
|
| Number of trading days of shares at $15.00 for the warrants to vest |
20
|
|
|
|
| Continuous trading period at the warrant strike price for the warrants to vest |
30 days
|
|
|
|